Do You Have a History of Non-Small Cell Lung Cancer (NSCLC)?

If you have been treated for NSCLC, you may qualify for a research study to learn if an investigational medication can help to prevent NSCLC from returning.

The Study at a Glance

The LIBRETTO-432 Study is seeking participants who have been treated for stage IB, II, or IIIA non-small cell lung cancer (NSCLC). The purpose of the study is to learn if an investigational medicine helps to prevent the return of NSCLC following standard treatment. People who are interested in participating can begin the screening process prior to completing their NSCLC treatment.


    Trial Details


    Non-small cell lung cancer (NSCLC)

    Potential Treatment Under Study



    What's Involved?

    Participation Length

    Up to 3 years


    About every 2 weeks


    Who Qualifies?



    Cancer Treatment Status

    Have received treatment


Researchers in over 200 locations globally are looking for volunteers for this research study. The map below shows research sites currently open for enrollment in your region. New sites may be added at a later date.

You may be reimbursed for travel or study-related expenses. For more information, please click the I'm Interested button to be connected with a research site.

Why Participate?

If you qualify, you're the only person who can decide if participation is right for you. Each person and each research study are different. Every research study has risks and benefits to consider when deciding to participate.

Adults with a history of stage IB, II, IIIA non-small cell lung cancer may want to take part in this research study for the following reasons.

    Advance Medicine

    Support important research for NSCLC medicines and possibly help others like you.

    Be Informed

    Find out if your NSCLC is RET fusion-positive and if it may have other genes associated with cancer growth.

    Explore Options

    Possibly try Selpercatinib or maybe learn of other targeted therapies you could be a good candidate to receive.

Are You Interested?

If you're interested in trying something new for your non-small cell lung cancer, you may be interested in our clinical trial.

About This Study

Want to learn more about the LIBRETTO-432 Study for non-small cell lung cancer? Visit the About This Study page for more information.